These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Is it too soon for mesenchymal stem cell trials in people with ALS?
    Author: Badayan I, Cudkowicz ME.
    Journal: Amyotroph Lateral Scler; 2008 Dec; 9(6):321-2. PubMed ID: 18819027.
    Abstract:
    Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting primarily the motor neurons. Stem cell therapy is under development as a possible treatment approach. A pilot study of intraspinal injections of mesenchymal stem cells (MSC) was conducted in 9 participants. We review this paper, the rationale, preclinical data and study design.
    [Abstract] [Full Text] [Related] [New Search]